Macrogenics Inc (NASDAQ: MGNX) is -54.46% lower on its value in year-to-date trading and has touched a low of $1.55 and a high of $19.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MGNX stock was last observed hovering at around $1.56 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $1.48, the stock is -30.76% and -42.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.95 million and changing -5.13% at the moment leaves the stock -57.46% off its SMA200. MGNX registered -89.73% loss for a year compared to 6-month loss of -50.67%. The firm has a 50-day simple moving average (SMA 50) of $2.556 and a 200-day simple moving average (SMA200) of $3.479075.
The stock witnessed a -40.56% gain in the last 1 month and extending the period to 3 months gives it a -54.18%, and is -29.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.76% over the week and 7.95% over the month.
Macrogenics Inc (MGNX) has around 341 employees, a market worth around $93.37M and $149.96M in sales. Profit margin for the company is -44.66%. Distance from 52-week low is -4.52% and -92.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.05%).
with sales reaching $9.59M over the same period.The EPS is expected to shrink by -140.19% this year, but quarterly earnings will post -58.33% year-over-year. Quarterly sales are estimated to grow 5.37% in year-over-year returns.
172.0 institutions hold shares in Macrogenics Inc (MGNX), with institutional investors hold 95.46% of the company’s shares. The shares outstanding are 62.82M, and float is at 58.00M with Short Float at 8.57%. Institutions hold 93.32% of the Float.
The top institutional shareholder in the company is BELLEVUE GROUP AG with over 9.94 million shares valued at $42.25 million. The investor’s holdings represent 15.8662 of the MGNX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 6.0 million shares valued at $25.5 million to account for 9.5749 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.4 million shares representing 8.6202 and valued at over $22.96 million, while VANGUARD GROUP INC holds 6.6388 of the shares totaling 4.14 million with a market value of $17.58 million.
Macrogenics Inc (MGNX) Insider Activity
The most recent transaction is an insider sale by Smith Beth Ann, the company’s VP, Controller & Treasurer. SEC filings show that Smith Beth Ann sold 423 shares of the company’s common stock on Feb 15 ’25 at a price of $2.56 per share for a total of $1083.0. Following the sale, the insider now owns 9532.0 shares.
Macrogenics Inc disclosed in a document filed with the SEC on Apr 04 ’24 that Peters Jeffrey Stuart (Senior VP and General Counsel) sold a total of 51,395 shares of the company’s common stock. The trade occurred on Apr 04 ’24 and was made at $15.55 per share for $0.8 million. Following the transaction, the insider now directly holds 0.0 shares of the MGNX stock.
